Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders
Hämostaseologie · 11.06.2026
DOI: 10.1055/a-2882-0640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 11.06.2026. Verfasst von Christina Hart und 3 weiteren Autor:innen. Beteiligte Einrichtung: University Hospital Regensburg, Department of Hematology and Oncology, Bavaria, Germany, Regensburg.
Abstract (Originalsprache)
Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) are acquired clonal disorders of hematopoiesis that typically cause thromboembolic and hemorrhagic complications. These include an increased risk of both arterial and venous thromboembolic events as well as a heightened bleeding tendency. Venous thromboembolic events frequently manifest at atypical sites and characteristically present as splanchnic vein thrombosis. A common cause of the elevated bleeding risk is acquired von Willebrand syndrome. Clinical indicators of an underlying MPN include thromboembolic events of unclear etiology or occurring at atypical sites, as well as acquired cutaneous or mucocutaneous bleeding tendencies. A hallmark of MPN in peripheral blood counts is hyperproliferation. Further diagnostic evaluation includes testing for the three major driver mutations (JAK2, CALR, MPL) and bone marrow biopsy. Management of thromboembolic event requires cytoreductive therapy and, depending on the site of thrombosis, antiplatelet therapy, and/or anticoagulation. Our review provides an overview of essential thrombocythemia, polycythemia vera, and primary myelofibrosis, as well as the hemostatic disorders associated with these conditions, focusing on diagnostic approaches and the prophylaxis and management of thromboembolic and bleeding complications.
Autor:innen und Institutionen
- University Hospital Regensburg, Department of Hematology and Oncology, Bavaria, Germany, Regensburg.
- Hannover Medical School, Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Lower Saxony, Germany, Hannover.
- University Medical Center Hamburg-Eppendorf, Oncology, Hematology and Bone Marrow Transplantation with the Section of Pneumology, Hamburg, Germany, Hamburg.
- Technical University Dresden, Department of Hematology and Oncology, Sachsen, Germany, Dresden.
ORCID-Profile: Christina Hart
Zitieren
APA
Hart, C., Tiede, A., Rolling, C. C., & Trautmann-Grill, K. (2026). Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders. Hämostaseologie. https://doi.org/10.1055/a-2882-0640
Vancouver
Hart C, Tiede A, Rolling CC, Trautmann-Grill K. Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders. Hämostaseologie. 2026. doi:10.1055/a-2882-0640
BibTeX
@article{Hart2026,
author = {Hart, Christina and Tiede, Andreas and Rolling, Christina C and Trautmann-Grill, Karolin},
title = {Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms—A Guide for Specialists in Coagulation Disorders},
journal = {Hämostaseologie},
year = {2026},
doi = {10.1055/a-2882-0640}
}
EUVIMED